Clinical Trial Update: Intranasal Insulin to Prevent Intensive Care Unit Delirium [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating intranasal insulin to prevent postoperative delirium in ICU patients, currently listed as Phase 2/3 and not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Delirium

Drugs mentioned

• Intranasal insulin (insulin)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Delirium - Postoperative | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING